Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study

Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study

Abstract Background Regional citrate anticoagulation (RCA) is recommended for continuous renal replacement therapy (CRRT). However, filter life varies and premature filter clotting can occur. The aims of this explorative prospective study were to investigate the effects of RCA on thrombin generation...

Full description

Bibliographic Details
Main Authors:	Richard Fisher, Gary W. Moore, Michael J. Mitchell, Letian Dai, Siobhan Crichton, Nuttha Lumlertgul, Marlies Ostermann
Format:	Article
Language:	English
Published:	SpringerOpen 2022-03-01
Series:	Annals of Intensive Care
Subjects:	Acute kidney injury Citrate Clotting CRRT Continuous renal replacement therapy Thrombin
Online Access:	https://doi.org/10.1186/s13613-022-01004-w

Similar Items

Construction and validation of a prediction model for the risk of citrate accumulation in patients with hepatic insufficiency receiving continuous renal replacement therapy with citrate anticoagulation
by: Quxia Hong, et al.
Published: (2024-01-01)

Fibrinolysis in Platelet Thrombi
by: Rahim Kanji, et al.
Published: (2021-05-01)

Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission
by: Valentina Pistolesi, et al.
Published: (2023-03-01)

Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study
by: Ying Yu, et al.
Published: (2018-07-01)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
by: Matthias Klingele, et al.
Published: (2017-11-01)

Revisiting the effect of cholesteryl sulfate on clotting and fibrinolysis: Inhibition of human thrombin and other human blood proteases
by: Rami A. Al-Horani
Published: (2024-03-01)

Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival
by: Monika Miklaszewska, et al.
Published: (2017-06-01)

The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
by: Richard Fisher, et al.
Published: (2017-10-01)

Prostacyclin analogues decrease platelet aggregation but have no effect on thrombin generation, fibrin clot structure, and fibrinolysis in pulmonary arterial hypertension: PAPAYA coagulation
by: Aleksander Siniarski, et al.
Published: (2022-10-01)

New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote
by: Mohamad Ammar Ayass, et al.
Published: (2023-09-01)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
by: Haixia Huang, et al.
Published: (2023-03-01)

Complications of regional citrate anticoagulation: accumulation or overload?
by: Antoine G. Schneider, et al.
Published: (2017-11-01)

Thrombin-induced platelet aggregation −effect of dabigatran using automated platelet aggregometry−
by: Mie Shimizu, et al.
Published: (2020-04-01)

Reference values for thrombin dynamics in platelet rich plasma
by: Qiuting Yan, et al.
Published: (2021-02-01)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
by: Yuelin Sun, et al.
Published: (2023-06-01)

Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023-10-01)

Personalized Medicine Transformed: ChatGPT’s Contribution to Continuous Renal Replacement Therapy Alarm Management in Intensive Care Units
by: Mohammad S. Sheikh, et al.
Published: (2024-02-01)

Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
by: Machteld Sillen, et al.
Published: (2021-04-01)

Thermodynamic, Anticoagulant, and Antiproliferative Properties of Thrombin Binding Aptamer Containing Novel UNA Derivative
by: Weronika Kotkowiak, et al.
Published: (2018-03-01)

Continuous Renal Replacement Therapy in the Critically Ill Patient: From Garage Technology to Artificial Intelligence
by: Sara Samoni, et al.
Published: (2021-12-01)

The clinical usefulness of measuring thrombin generation
by: Coenraad H. Hemker
Published: (2023-03-01)

Simple citrate anticoagulation protocol for low flux haemodialysis
by: Eng Kuang Lim, et al.
Published: (2018-01-01)

Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
by: Marco Ranucci, et al.
Published: (2020-10-01)

Application of thrombin powder after tooth extraction in patients receiving anticoagulant therapy
by: Marjanović Marjan
Published: (2002-01-01)

Thrombin generation in different commercial sodium citrate blood tubes
by: Luca Salvagno Gian, et al.
Published: (2020-01-01)

Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis
by: Wei Zhang, et al.
Published: (2019-01-01)

Regression of Atherosclerosis in ApoE−/− Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel “Cytotopic” Anti‐Thrombin Without Prolonged Anticoagulation
by: Daxin Chen, et al.
Published: (2020-07-01)

Kinetics of the inhibition of thrombin by hirudin /
by: 236620 Stone, Stuart R., et al.

Thrombin structure and function : why thrombin is the primary target for antithrombotics /
by: Fenton, John W.

Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay
by: Audrey Carlo, et al.
Published: (2022-07-01)

Targeting Platelet Thrombin Receptor Signaling to Prevent Thrombosis
by: Susan S. Smyth, et al.
Published: (2013-08-01)

Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation
by: Giovana Seno Di Marco, et al.
Published: (2024-03-01)

Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor
by: Yideng Liang, et al.
Published: (2023-08-01)

Comparison of citrate dialysate in pre- and post-dilution online hemodiafiltration: effect on clot formation and adequacy of dialysis in hemodialysis patients
by: Pasu Nakornchai, et al.
Published: (2024-12-01)

A Rare Case of Severe Metabolic Alkalosis with Unusual Hyperproteinemia Treated with Continuous Renal Replacement Therapy and Regional Citrate Anticoagulation
by: Vojtěch Matoušek, et al.
Published: (2018-08-01)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
by: Fang Hu, et al.
Published: (2022-10-01)

Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus
by: Shu-Yuan Liu, et al.
Published: (2023-05-01)

Exploring potential anticoagulant drug formulations using thrombin generation test
by: Elena Zavyalova, et al.
Published: (2016-03-01)

Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging
by: Jérémy Lagrange, et al.
Published: (2017-11-01)

A simple activity assay for thrombin and hirudin /
by: 350239 Dang, Q. D., et al.